Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grossman

Showing results (521-530 of 712) with videos related to

Pageof 72
Sort By:
The Journal of Emergency Medicine|December 20, 2015
Comparison of 1-Day Emergency Department Observation and Inpatient Ward for 1-Day Admissions in Syncope PatientsAtira M Grossman, Katherine A Volz, Nathan I Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy studyL Kleinberg, S A Grossman, K Carson, et al.
Neuro-Oncology Practice|April 8, 2020
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncologySurabhi Ranjan, Nebojša Skorupan, Xiaobu Ye, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor TherapyS A Grossman, F Hochberg, J Fisher, et al.
Clinical Endocrinology|February 1, 1988
A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's diseaseA C Hale, P J Coates, I Doniach, et al.
Clinical Endocrinology|January 1, 1981
The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxoneA Grossman, P J Moult, R C Gaillard, et al.
Neuro-Oncology|July 29, 2004
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literatureMary Y Armanios, Stuart A Grossman, Stephen C Yang, et al.
Cancer Investigation|July 15, 2014
Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomasRyan P Lange, Allen Everett, Pratima Dulloor, et al.
Neuro-Oncology|May 15, 2008
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant gliomaSurasak Phuphanich, Kathryn A Carson, Stuart A Grossman, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretionR H Skelly, M Korbonits, A Grossman, et al.
Pageof 72

Showing results (521-530 of 712) with videos related to

Sort By:
Pageof 72
The Journal of Emergency Medicine|December 20, 2015
Comparison of 1-Day Emergency Department Observation and Inpatient Ward for 1-Day Admissions in Syncope PatientsAtira M Grossman, Katherine A Volz, Nathan I Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy studyL Kleinberg, S A Grossman, K Carson, et al.
Neuro-Oncology Practice|April 8, 2020
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncologySurabhi Ranjan, Nebojša Skorupan, Xiaobu Ye, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor TherapyS A Grossman, F Hochberg, J Fisher, et al.
Clinical Endocrinology|February 1, 1988
A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's diseaseA C Hale, P J Coates, I Doniach, et al.
Clinical Endocrinology|January 1, 1981
The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxoneA Grossman, P J Moult, R C Gaillard, et al.
Neuro-Oncology|July 29, 2004
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literatureMary Y Armanios, Stuart A Grossman, Stephen C Yang, et al.
Cancer Investigation|July 15, 2014
Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomasRyan P Lange, Allen Everett, Pratima Dulloor, et al.
Neuro-Oncology|May 15, 2008
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant gliomaSurasak Phuphanich, Kathryn A Carson, Stuart A Grossman, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretionR H Skelly, M Korbonits, A Grossman, et al.
Pageof 72